Stock Market News1 week WST Stock Declines in Pre-Market Despite Q4 Earnings Beat, Margins Down Zacks
West Pharmaceutical’s overall top line in the fourth quarter of 2024 continues to benefit from revenue growth in its Proprietary Products segment.
XWest Pharmaceutical’s overall top line in the fourth quarter of 2024 continues to benefit from revenue growth in its Proprietary Products segment.
X